Study S003192

Investigating the Exposure of NNC0487-0111 in Different Oral Formulations and the Effect of Food Intake on Pharmacokinetics of NNC0487-0111 in Participants With Overweight or Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06478563
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: SINGLE
Status: COMPLETED
Enrollment: 133
Start: 2024-06-27
Primary completion: 2025-06-05
Lead sponsor: Novo Nordisk A/S
Conditions: Obesity; Overweight
Interventions: DRUG:NNC0487-0111 (formulation D); DRUG:NNC0487-0111 (formulation C)
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1300-3720

Registered primary outcomes

Phase A: The area under the NNC0487-0111 plasma concentration-time curve during a dosing interval at steady state [From pre-dose to after dosing on days 21, 42, 63, 84, 105 and 126]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.